309
Views
1
CrossRef citations to date
0
Altmetric
Research Article

The Experience of Physicians in Pharmacogenomic Clinical Decision Support Within Eight German University Hospitals

, , , , , , , , , , & show all
Pages 773-785 | Received 01 Feb 2017, Accepted 21 Mar 2017, Published online: 08 Jun 2017

References

  • Association of Research-Based Pharmaceutical Companies . In Deutschland zugelassene Arzneimittel für die personalisierte Medizin [Licensed drugs for personalized medicine in Germany] ( 2017 ). https://www.vfa.de/de/arzneimittel-forschung/datenbanken-zu-arzneimitteln/individualisierte-medizin.html .
  • Stanek EJ , SandersCL , TaberKAJet al. Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey . Clin. Pharmacol. Ther.91 ( 3 ), 450 – 458 ( 2012 ).
  • Overby CL , ErwinAL , Abul-husnNSet al. Physician attitudes toward adopting genome-guided prescribing through clinical decision support . J. Pers. Med.4 , 35 – 49 ( 2014 ).
  • Johansen Taber KA , DickinsonBD . Pharmacogenomic knowledge gaps and educational resource needs among physicians in selected specialties . Pharmgenomics Pers. Med.7 , 145 – 162 ( 2014 ).
  • Devine EB , LeeC-J , OverbyCLet al. Usability evaluation of pharmacogenomics clinical decision support aids and clinical knowledge resources in a computerized provider order entry system: a mixed methods approach . Int. J. Med. Inform.83 ( 7 ), 473 – 483 ( 2014 ).
  • Klitzman R , ChungW , MarderKet al. Attitudes and practices among internists concerning genetic testing . J. Genet. Couns.22 ( 1 ), 90 – 100 ( 2013 ).
  • Unertl KM , FieldJR , PriceL , PetersonJF . Clinician perspectives on using pharmacogenomics in clinical practice . Per. Med.12 ( 4 ), 339 – 347 ( 2015 ).
  • Romagnoli KM , BoyceRD , EmpeyPE , AdamsS , HochheiserH . Bringing clinical pharmacogenomics information to pharmacists: a qualitative study of information needs and resource requirements . Int. J. Med. Inform.86 , 54 – 61 ( 2016 ).
  • Gottesman O , ScottSA , EllisSBet al. The CLIPMERGE PGx Program: clinical implementation of personalized medicine through electronic health records and genomics-pharmacogenomics . Clin. Pharmacol. Ther.94 ( 2 ), 214 – 217 ( 2013 ).
  • Rogausch A , PrauseD , SchallenbergA , BrockmöllerJ , HimmelW . Patients’ and physicians’ perspectives on pharmacogenetic testing . Pharmacogenomics7 ( 1 ), 49 – 59 ( 2006 ).
  • Shuldiner AR , RellingMV , PetersonJFet al. The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation . Clin. Pharmacol. Ther.94 ( 2 ), 207 – 210 ( 2013 ).
  • Haga S , BurkeW , GinsburgG , MillsR , AgansR . Primary care physicians’ knowledge of and experience with pharmacogenetic testing . Clin. Genet.82 ( 4 ), 388 – 394 ( 2012 ).
  • Bellcross CA , KolorK , GoddardKAB , CoatesRJ , ReyesM , KhouryMJ . Awareness and utilization of BRCA1/2 testing among U.S. primary care physicians . Am. J. Prev. Med.40 ( 1 ), 61 – 66 ( 2011 ).
  • Trivers KF , BaldwinLM , MillerJWet al. Reported referral for genetic counseling or BRCA1/2 testing among United States physicians: a vignette-based study . Cancer117 ( 23 ), 5334 – 5343 ( 2011 ).
  • White DB , BonhamVL , JenkinsJ , StevensN , McBrideCM . Too many referrals of low-risk women for BRCA1/2 genetic services by family physicians . Cancer Epidemiol. Biomarkers Prev.17 ( 11 ), 2980 – 2986 ( 2008 ).
  • Brenner SK , KaushalR , GrinspanZet al. Effects of health information technology on patient outcomes: a systematic review . J. Am. Med. Informatics Assoc.23 ( 5 ), 1016 – 1036 ( 2016 ).
  • Gammal RS , CrewsKR , HaidarCEet al. Pharmacogenetics for safe codeine use in sickle cell disease . Pediatrics138 ( 1 ), e20153479 ( 2016 ).
  • PharmGKB ( 2017 ). www.pharmgkb.org/ .
  • MacKenzie M , HallR . Pharmacogenomics and pharmacogenetics for the intensive care unit: a narrative review . Can. J. Anesth.64 ( 1 ), 45 – 64 ( 2017 ).
  • Hernandez A , FleurenceR , RothmanR . The ADAPTABLE trial and PCORnet: shining light on a new research paradigm . Ann. Intern. Med.163 ( 8 ), 635 – 636 ( 2015 ).
  • Corley DA , FeigelsonHS , LieuTA , McGlynnEA . Building data infrastructure to evaluate and improve quality: PCORnet . J. Oncol. Pract.11 ( 3 ), 204 – 206 ( 2015 ).
  • Hripcsak G , DukeJD , ShahNHet al. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers . Stud. Health Technol. Inform.216 , 574 – 578 ( 2015 ).
  • Lablans M , KadiogluD , MateS , LebI , ProkoschH-U , ÜckertF . Strategien zur Vernetzung von Biobanken . Bundesgesundheitsblatt - Gesundheitsforsch - Gesundheitsschutz59 ( 3 ), 373 – 378 ( 2016 ).
  • Sankar PL , ParkerLS . The precision medicine initiative's all of us research program: an agenda for research on its ethical, legal, and social issues . Genet. Med. doi:10.1038/gim.2016.183 ( 2016 ) ( Epub adead of print ).
  • Peplow M . The 100 000 genomes project . BMJ13 ( 353 ), i1757 ( 2016 ).
  • German Federal Ministry of Education and Research . Medical informatics funding scheme: networking data – improving health care . 1 – 18 ( 2015 ). www.bmbf.de/pub/Medical_Informatics_Funding_Scheme.pdf .
  • MIRACUM . www.miracum.de .
  • von Elm E , AltmanDG , EggerM , PocockSJ , G⊘tzschePC , VandenbrouckeJP . The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies . J. Clin. Epidemiol.61 ( 4 ), 344 – 349 ( 2008 ).
  • de Denus S , LetarteN , HurlimannTet al. An evaluation of pharmacists’ expectations towards pharmacogenomics . Pharmacogenomics14 ( 2 ), 165 – 175 ( 2013 ).
  • Hu PJ-H , ChauPYK , Liu ShengOR . Adoption of telemedicine technology by health care organizations: an exploratory study . J. Organ. Comput. Electron. Commer.12 ( 3 ), 197 – 221 ( 2002 ).
  • Gagnon MP , GhandourEK , TallaPKet al. Electronic health record acceptance by physicians: testing an integrated theoretical model . J. Biomed. Inform.48 , 17 – 27 ( 2014 ).
  • Abdekhoda M , AhmadiM , GohariM , NoruziA . The effects of organizational contextual factors on physicians’ attitude toward adoption of electronic medical records . J. Biomed. Inform.53 , 174 – 179 ( 2015 ).
  • SoSci Survey . www.soscisurvey.de .
  • Lehrstuhl für Medizinische Informatik . www.imi.med.fau.de/introduction-videos/ .
  • Grimm P . Pretesting a questionnaire . In : Wiley International Encyclopedia of Marketing . Wiley International , NJ, USA ( 2010 ).
  • Devine EB , PatelR , DixonDR , SullivanSD . Assessing attitudes toward electronic prescribing adoption in primary care: a survey of prescribers and staff . Inform. Prim. Care18 ( 3 ), 177 – 187 ( 2011 ).
  • Weinshilboum R . Inheritance and drug response . N. Engl. J. Med.348 ( 6 ), 529 – 537 ( 2003 ).
  • The Royal Society . Personalised medicines: hopes and realities . The Royal Society1 – 52 , September 2005 .
  • Beaulieu M , de DenusS , LachaineJ . Systematic review of pharmacoeconomic studies of pharmacogenomic tests . Pharmacogenomics11 ( 11 ), 1573 – 1590 ( 2010 ).
  • Crews KR , CrossSJ , McCormickJNet al. Development and implementation of a pharmacist-managed clinical pharmacogenetics service . Am. J. Heal. Syst. Pharm.68 ( 2 ), 143 – 150 ( 2011 ).
  • O'Connor SK , FerreriSP , MichaelsNMet al. Exploratory planning and implementation of a pilot pharmacogenetic program in a community pharmacy . Pharmacogenomics13 ( 8 ), 955 – 962 ( 2012 ).
  • Vozikis A , CooperDN , MitropoulouCet al. Test pricing and reimbursement in genomic medicine: towards a general strategy . Pub. Heal. Genom.19 ( 6 ), 352 – 363 ( 2016 ).
  • Zika E , GurwitzD , IbarretaD . Pharmacogenetics and pharmacogenomics: state-of-the-art and potential socio-economic impact in the EU . IPTS 22214 , 174 ( 2006 ).
  • Minarro-Gimenez JA , BlagecK , BoyceRD , AdlassnigK-P , SamwaldM . An ontology-based, mobile-optimized system for pharmacogenomic decision support at the point-of-care . PLoS ONE9 ( 5 ), e93769 ( 2014 ).
  • Blagec K , RomagnoliKM , BoyceRD , SamwaldM . Examining perceptions of the usefulness and usability of a mobile-based system for pharmacogenomics clinical decision support: a mixed methods study . PeerJ4 , e1671 ( 2016 ).
  • Dunnenberger HM , CrewsKR , HoffmanJMet al. Preemptive clinical pharmacogenetics implementation: current programs in five United States medical centers . Annu. Rev. Pharmacol. Toxicol.55 , 89 – 106 ( 2015 ).
  • Teng K , DiPieroJ , MeeseTet al. Institutional profile: Cleveland Clinic's Center for Personalized Healthcare: setting the stage for value-based care . Pharmacogenomics15 ( 5 ), 587 – 591 ( 2014 ).
  • Hicks JK , DunnenbergerHM , GumpperKF , HaidarCE , HoffmanJM . Integrating pharmacogenomics into electronic health records with clinical decision support . Am. J. Heal. Pharm.73 ( 23 ), 1967 – 1976 ( 2016 ).
  • Peterson JF , BowtonE , FieldJRet al. Electronic health record design and implementation for pharmacogenomics: a local perspective . Genet. Med.15 ( 10 ), 833 – 841 ( 2013 ).
  • Pulley JM , DennyJC , PetersonJFet al. Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project . Clin. Pharmacol. Ther.92 ( 1 ), 87 – 95 ( 2012 ).
  • Overby CL , DevineEB , AbernethyN , McCuneJS , Tarczy-HornochP . Making pharmacogenomic-based prescribing alerts more effective: a scenario-based pilot study with physicians . J. Biomed. Inform.55 ( 4 ), 249 – 259 ( 2015 ).
  • Nishimura AA , ShirtsBH , DorschnerMOet al. Development of clinical decision support alerts for pharmacogenomic incidental findings from exome sequencing . Genet. Med.17 ( 11 ), 939 – 942 ( 2015 ).
  • Rohrer Vitek CR , NicholsonWT , SchultzC , CaraballoPJ . Evaluation of the use of clinical decision support and online resources for pharmacogenomics education . Pharmacogenomics16 ( 14 ), 1595 – 1603 ( 2015 ).
  • Schmitz S , HallekM . Zukunft der onkologischen Versorgung: Kooperation ist der Schlüsse . Dtsch. Arztebl.109 ( 29–30 ), 1478 – 1480 ( 2012 ).
  • MIRACUM . About Us . www.miracum.de/index.php/about-us/ .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.